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Abstract
Background: Mass spectrometry (MS) is an essential analytical tool in proteomics. Many existing algorithms for
peptide detection are based on isotope template matching and usually work at different charge states separately,
making them ineffective to detect overlapping peptides and low abundance peptides.
Results: We present BPDA, a Bayesian approach for peptide detection in data produced by MS instruments with
high enough resolution to baseline-resolve isotopic peaks, such as MALDI-TOF and LC-MS. We model the spectra
as a mixture of candidate peptide signals, and the model is parameterized by MS physical properties. BPDA is
based on a rigorous statistical framework and avoids problems, such as voting and ad-hoc thresholding, generally
encountered in algorithms based on template matching. It systematically evaluates all possible combinations of
possible peptide candidates to interpret a given spectrum, and iteratively finds the best fitting peptide signal in
order to minimize the mean squared error of the inferred spectrum to the observed spectrum. In contrast to
previous detection methods, BPDA performs deisotoping and deconvolution of mass spectra simultaneously, which
enables better identification of weak peptide signals and produces higher sensitivities and more robust results.
Unlike template-matching algorithms, BPDA can handle complex data where features overlap. Our experimental
results indicate that BPDA performs well on simulated data and real MS data sets, for various resolutions and signal
to noise ratios, and compares very favorably with commonly used commercial and open-source software, such as
flexAnalysis, OpenMS, and Decon2LS, according to sensitivity and detection accuracy.
Conclusion: Unlike previous detection methods, which only employ isotopic distributions and work at each single
charge state alone, BPDA takes into account the charge state distribution as well, thus lending information to
better identify weak peptide signals and produce more robust results. The proposed approach is based on a
rigorous statistical framework, which avoids problems generally encountered in algorithms based on template
matching. Our experiments indicate that BPDA performs well on both simulated data and real data, and compares
very favorably with commonly used commercial and open-source software. The BPDA software can be
downloaded from http://gsp.tamu.edu/Publications/supplementary/sun10a/bpda.
Background
Mass spectrometry (MS) is a key analytical tool in pro-
teomics. A mass spectrometer measures the concentra-
tion of ionized molecules at a range of mass-to-charge
ratios (m/z). MS instruments consist of three modules:
an ionization source, a mass analyzer and a detector
which captures the ions and measures the intensity of
each ion species. Widely used ionization methods
include electrospray ionization (ESI) [1] and matrix-
assisted laser desorption/ionization (MALDI) [2,3]. Mass
analyzers separate the ions according to their mass-to-
charge ratios. There are several types of mass analyzers
including the Orbitrap [4], Quadrupole [5], Time-of-
Flight (TOF) [6,7], and fourier transform ion cyclotron
resonance (FTICR) [8]. Liquid Chromatography (LC) is
often coupled with MS to achieve additional separation
of peptides and thus reduce the complexity of an indivi-
dual mass spectrum. Before entering the mass spectro-
meter, peptide species pass through a LC column with
different speeds depending on their physicochemical
properties and interactions with the solvent [9]. A single
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sands of mass spectra sampled during the LC elution
process.
Peptide detection, which converts raw spectra to a list
of peptide masses, is usually the first step in protein MS
data processing. It directly affects the accuracy of subse-
quent analyses such as protein identification and quanti-
fication, data alignment between multiple experiments,
biomarker discovery and classification of different sam-
ples. One difficulty in peptide detection is that a peptide
species may register several peaks in the spectra due to
the following two points: First, a peptide species may
take different numbers of charges during ionization,
therefore its peaks can be observed at different charge
states. Second, at a given charge state, several peaks can
be observed due to heavy isotopes (e.g.
13C), which are
commonly referred to as isotopic peaks or the isotope
series. The isotopic distribution of a peptide can be deter-
mined by the elemental formula of the peptide and the
natural abundance of heavy isotopes, and therefore
known [10]. When mass spectra have low resolution in
which isotopic peaks cannot be baseline resolved (i.e. the
isotopic peaks convolve together to form isotope envel-
opes, and only one peak can be observed for one peptide
at a given charge state), and when peptides are singly
charged as commonly observed in MALDI, to report
each detected peak as a peptide feature might be suffi-
cient as in [11-14]. But for high resolution spectra,
reporting each observed peak as a unique peptide species
would give rise to too many false positives. Thus a variety
of algorithms for deisotoping and charge states deconvo-
lution have been proposed. Many of these algorithms
such as PepList [15], msInspect [16], Noy’s method [17],
Decon2LS [18], and OpenMS [19] are based on template
matching. Templates employed in the first four algo-
rithms are based on 1 D theoretic isotope patterns pre-
dicted from peptide masses [20-22], while the last
algorithm combines isotope patterns (along the m/z
dimension) with elution peaks (along the elution time
dimension) to form 2 D templates. If the observed signal
(a cluster of peaks) matches the proposed template
well – the quality of the match is assessed by a fitting
score – it will be reported as a feature and then sub-
tracted from the spectrum. The process iterates until no
more matches can be found. The major problem of this
matching and subtraction process is that it may be inef-
fective to detect overlapping peptides. In the case of over-
lapping (e.g. one doubly charged peptide can overlap with
as i n g l yc h a r g e dp e p t i d eo fh a l ft h em a s s ) ,i ft h ep e a k
cluster of one peptide is incorrectly matched and sub-
tracted, the rest of the peptides can not be detected cor-
rectly based on the remaining spectrum, which will cause
error propagation. Besides, each predicted template is
based on a single peptide and it can not match the
observed overlapping peaks well, which renders a low
quality match and reduces the sensitivities of these algo-
rithms. In addition to these algorithms based on template
matching, Du et al. developed an algorithm based on
variable selection [10]. The key idea is to select the least
number of candidate isotope series to explain the spec-
trum, and hence find the corresponding peptides. But the
superimposed criterion “selecting the least number of
candidates” is not justified. In fact, while this criterion
may result in a desirable reduction of the false detection
rate, the sensitivity may be reduced as well. Zhang et. al.
[23] proposed a Bayesian approach for peptide ion peak
detection. A model for the m/z interval of one dalton was
developed, a Bayesian approach was applied to estimate
the model parameters based on the observed spectrum,
and the existence probability of a peptide ion peak at
each charge state and isotope position was calculated.
Note that this algorithm did not perform peptide level
peak detection as what we are proposing in this paper.
The authors reported that their method had better sensi-
tivity results than the wavelet based algorithms when
tested by simulated data and eight sets of real prOTOF
MS data. In this paper, we propose a Bayesian Peptide
Detection Algorithm (BPDA), which is basically an exten-
sion of Zhang’s method. The difference being that a
model for the whole spectrum is developed, and both iso-
tope patterns and charge state distributions of peptides
are considered in our method.
The proposed method, BPDA, can be applied to data
generated by MS instruments with mass resolutions
high enough to baseline-resolve isotopic peaks. BPDA
evaluates all possible combinations of possible peptide
candidates (originated from well-defined peaks of the
raw spectrum – see Methods section for more details)
to interpret a given spectrum, and iteratively finds the
best fitting peptide parameters (peptide peak heights,
existence probabilities, etc.) in order to minimize the
mean squared error of the inferred spectrum to the
observed spectrum. BPDA offers the following four
advantages: Firstly, since BPDA looks for the optimal
among all possible interpretations of the MS spectra,
the procedure is thus systematic. In contrast, the afore-
mentioned template-matching methods are greedy. They
cannot evaluate all potential interpretations of a given
spectrum. Hence, they are neither systematic nor opti-
mal. Besides, many methods do not include all possible
peptide candidates, especially the ones with low abun-
dance in the first place, and the sensitivity is reduced
compared to BPDA. Secondly, BPDA considers all
charge states and isotopic peaks of peptides for detec-
tion. It is noted that multiply charged peptides can reg-
ister peaks at several charge states, but deisotoping and
charge state deconvolution are often dealt with sepa-
rately in many algorithms [10,16-19,24]. While high
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abundance charge states might be missed or wrongly
assigned, rendering low sensitivity results in peptide
identification and inaccuracy in peptide quantification.
In contrast, BPDA combines the information of isotopic
peaks at different charge states as a whole to detect one
peptide, lending information to better identify weak pep-
tide signals. Thirdly, BPDA provides existence probabil-
ities for all the peptides considered, as opposed to the
fitting scores generally provided by template-matching
methods, the benefits being that the existence probabil-
ities can be directly used for probability-based evalua-
tion of peptides and confident peptide detection similar
to that of PeptideProphet [25], which is a popular soft-
ware used for LC-MS/MS peptide identification. Finally,
most of the parameters in the proposed method possess
a clear physical meaning, since they come directly from
the observation of the mass spectra. In contrast, many
other approaches require the selection of numerous
nonintuitive parameters, such as wavelet functions and
coefficients [11-13].
Methods
For 1 D MS spectrum, we first perform spectrum prepro-
cessing to remove the baseline, filter the noise and gener-
ate a list of peptide candidates. Then BPDA is applied
based on the developed MS model to infer the best fitting
peptide signals of the observed spectrum, the results being
peptide abundances, existence probabilities and so on. For
2 D LC-MS spectra, we first detect peptide elution peaks
along the retention time dimension, and build elution
peak groups by collecting the peaks which have similar
retention time together using a method similar to [24].
Each group contains a series of consecutive spectra, which
are then averaged to form a mean spectrum. The rationale
of using a mean spectrum to represent the group is that
the noise of consecutive spectra could be canceled out to a
certain degree [11]. The BPDA algorithm is then applied
to each of the mean spectra, and finally an overall peptide
list is generated. The details of the preprocessing step, the
proposed MS model, and the BPDA algorithm are
described in the following subsections.
Spectrum preprocessing and obtaining peptide
candidates
A non-flat baseline is often observed in mass spectra, the
presence of which can distort the true signal pattern. Thus
the first preprocessing step is to detect and subtract the
baseline from MS spectra. We use the minimum of a slid-
ing window along the m/z axis as the baseline, similar to
the method used in [10]. The next step is peak detection.
We use the Matlab function “mspeaks” [26] to perform
this task. The algorithm first identifies all local maxima in
the wavelet denoised spectrum as putative peak locations.
Then peaks are filtered based on their intensities and sig-
nal to noise ratios. The last step of preprocessing is to
obtain a list of peptide candidates. Considering one
detected peak with centroid at m/z value d,w ew a n tt o
find out which peptides can potentially register a peak at
this position. The answer is given below in terms of the
masses of such peptides:
mass i d m jm i cs j iso pc nt =− − = … = … ( ) , , ,, , , ,,, 12 01 (1)
where mass is the mass of one peptide candidate, mpc
is the mass of one positive charge and mnt is the mass
shift caused by addition of one neutron. Due to mass
defect, the mass shift varies for different elements. We
approximate mnt using the mass shift from
13C to
12C,
which is 1.0034, since Carbon contributes most to the
isotope patterns. This approximation works well if the
mass calibration of the instrument is correct. The para-
meters cs and iso are user defined maximum numbers
of considered charge states and isotopic positions,
respectively. It is easy to see from the above equation
that each detected peak gives rise to cs ×( iso + 1) differ-
ent peptide candidates (masses). These candidates
exhaust all the possibilities to generate the peak with
centroid d, but it does not follow that all the candidates
really exist in the sample. Therefore, our primary goal
in peptide detection is to find the existence probability
of each peptide candidate. Also note that the total num-
ber of candidates should be less than or equal to cs ×
(iso + 1) × number of detected peaks, as is possible that
multiple peaks yield the same candidate mass.
Modeling the mass spectrum
Suppose N peptide candidates are obtained from the
observed spectrum using the method described in the
previous section. Each candidate can generate a series of
peaks over different charge states, and at each charge
state several isotopic peaks can be registered. The signal
generated by the kth peptide candidate is thus modeled
by the following equation, in which i and j represent the
charge state and the isotopic position of the candidate
peptide, respectively:
gx c f x m M km k i j
j
iso
i
cs
mk i jk i j () (; , ) , , ,,, ,, , == …
= = ∑ ∑
0 1
12  (2)
where the peak shape function is given by
fx e mk i jk i j
x ki j m ki j ;, ,,
() ,, 
 () =  
2
. That is, the peak is
modeled as Gaussian-shaped, as in [27]. It is reported that
the Gaussian-shaped peak approximates the reality well
enough to obtain good detection results [17]. Still, this peak
shape function can be adjusted for different instruments
without affecting the overall structure of the algorithm.
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erated by the N peptide candidates plus Gaussian ran-
dom noise, which can be modeled as:
yg x c f x mk k
k
N
mm k
k
N
ki j
j
iso
i
cs
mk i jk =+ =
== = = ∑∑ ∑ ∑  
11 0 1
() (; , ,,  λ , , )
,, , , ,
ij
m mM += …  12
(3)
I nt h ea b o v et h r e ee q u a t i o n s ,xm is the mth mass-to-
charge ratio (m/z) in the spectrum, ym is the observed
intensity at xm, M is the number of observations, and
m is Gaussian random noise with zero mean and
standard deviation s. The value of can be approxi-
mated by the standard deviation of the background
region in the spectrum. Note that we model m as
additive Gaussian which is generally a good model for
t h et h e r m a ln o i s ei ne l e c t r o n i ci n s t r u m e n t s .T h e r ea r e
reports of non-Gaussian noise in FTMS [28] and thus
it is safer to apply the proposed algorithm to TOF MS
instruments [29]. The parameters of the kth candidate,
namely, ak,ij, rk,ij, lk and ck,ij are discussed in detail
below:
￿ ak,ij is the theoretic centroid (m/z value) of the
peak generated by candidate k,a tc h a r g es t a t ei and
isotopic number j.
ki j
massk impc jmnt
i
ic s ji s o , , , ,, , , ,,, =
++
=… =… 12 01 (4)
where massk is the mass of the kth candidate. Since the
candidate’s mass is already obtained, ak, ij can be calculated.
￿ rk,ij relates to the shape (width) of the peak cen-
tered at ak,ij. It can be estimated by using its rela-
tionship to the peak’s Full Width at Half Maximum
(FWHM): ki j , ln / = 22 2F W H M .
￿ lk is an indicator random variable, which is 1 if the
kth peptide candidate truly exists in the sample and
0 otherwise.
￿ ck,ij is the height (i.e. intensity) of the peak gener-
ated by peptide k, at charge state i and isotopic
number j.
In summary, the model considers peaks at different
isotopic positions and charge states simultaneously for
each peptide candidate, incorporating candidates’ exis-
tence probabilities and the spectrum thermal noise.
Bayesian peptide detection
Let
  {, ; ,,, ,,, ,,} , kk i j ck N i c s j i s o =… =… =… 110
be the set of all the unknown model parameters. The
goal of our algorithm is to d e t e r m i n et h ev a l u eo fθ
based on the observed spectrum y =[ y1,..., yM ]
T .I n
fact, the value of lk is of our prime interest for the pep-
tide detection problem. For this purpose, we can use a
Bayesian approach to first obtain the a posteriori prob-
ability (APP) of all the parameters, P (θ | y). Then the
APPs P (lk|y), k = 1, ..., N, can be obtained by integra-
tion of the joint posterior distribution P (θ | y)o v e ra l l
parameters except lk. Clearly, the calculation involves
high dimension integration which is not an easy task.
Besides, due to the highly nonlinear nature of the data
model, none of the desired APPs can be obtained analy-
tically. To overcome the computational obstacle, we
resort to the Gibbs sampling method [30], which is a
variant of the Markov Chain Monte Carlo (MCMC)
approach [31], to sample the model parameters.
Gibbs sampling is an iterative scheme, which uses the
popular strategy of divide-and-conquer to sample a subset
of parameters at a time while fixing the rest at the sample
values from the previous iteration, as if they were true. In
other words, for the lth parameter group θl,w es a m p l e
from the conditional posterior distribution P(θl|θ-l, y),
where θ -l ≜ θ\θl. After this sampling process iterates
among the parameter groups for a sufficient number of
cycles (which is referred to as the “burn-in” period), con-
vergence is reached. The samples collected afterwards are
shown to be from the marginal posterior distribution
P(θl|y), which is independent of θ-l, and thus these samples
can be used to estimate the target parameters.
The Gibbs sampling process for the kth peptide candi-
date and the derivations of the conditional posterior dis-
tributions of important model parameters are briefly
summarized below. The detailed derivations can be
found in Additional file 1.
￿ Sample the peak height vector ck ≜ [ck,ij; i = 1,...,
cs, j = 0,..., iso]
T for the kth peptide candidate
The heights of all the possible peaks (over different
charge states and isotopic positions) of the kth pep-
tide candidate are included in the peak height vector
ck and are sampled simultaneously from the condi-
tional posterior distribution of ck, which, by the
Bayesian principle, is proportional to the likelihood
times the prior:
PP P kk k (| , ) ( | ) () , cy y c c    − ∝ (5)
where    −ck k  \c .
The derivations of the likelihood, the prior distribu-
tion and the conditional posterior distribution of ck
are given in Additional file 1.
￿ Sample the peptide existence indicator variable lk
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Pp p kk k (| , ) ( | ) ()     yy − ∝
where    − k k  \ .
The derivations of the likelihood, the prior distribu-
tion and the conditional posterior distribution of lk
are given in Additional file 1
The complexity of the proposed Gibbs sampling algo-
rithm is determined by two factors: (1) the sheer num-
ber of peptide candidates, and (2) the correlation
between parameters that need to be sampled. The algo-
rithm complexity grows exponentially with the number
of peptide candidates, and the correlation between para-
meters reduces the sampling efficiency. To address these
two issues, we first partition non-overlapping peptide
candidates into different groups. The proposed algo-
rithm can be applied to each group in a parallel manner
and the algorithm complexity is reduced, because within
each group the number of candidates is reduced, and
the corresponding signal-containing spectrum region is
restricted. Peptide candidates within each group are
then clustered by the k-means clustering algorithm [32],
the distance measure being the correlation between pep-
tide candidate signals. Peptide candidates within a clus-
ter have strong correlations among each other, and their
indicator variables are sampled from the joint condi-
tional posterior distribution. These two measures
improve the overall efficiency of the algorithm. The
pseudocode of the entire Gibbs sampling process is
given in Additional file 2: Table S1.
The samples taken after convergence can be used to
estimate the target parameters. Particularly, the exis-
tence probability of peptide k is calculated as
P
Rr
kk
r
rr
R
(| ) ,  ==
−+
= ∑ 1
1
0 1
0
y (6)
where r0 is the first iteration after convergence is
reached, R is the total number of iterations, and k
r is
the sample value of lk in the rth iteration. The kth pep-
tide candidate is said to be detected if its existence
probability P(lk =1 | y) is greater than a predefined
threshold.
Results
We report below the observed performance of BPDA,
side by side with well-known tools, such as OpenMS
and Decon2LS, in a number of experiments using both
synthetic and real data.
Synthetic data
It is difficult to evaluate the performance of a given
detection method using real data due to the existence of
unpredictable contaminants and the unknown true com-
position of the samples. The merit of using simulated
data is that the ground truth is known and thus algo-
rithm evaluation can be carried out [27,29].
Synthetic 20-mix spectra with different abundance levels
(SNRs)
First, to test the robustness of our algorithm, we gen-
erated MS data sets with different signal to noise ratios
(SNRs), using the method described in [27]. In fact, the
mean signal strength (i.e., peptide abundance) was var-
ied while the noise level (i.e., the mean and variance of
the noise) was fixed. For each peptide abundance level
a, a Î {500, 2500, 12500}, the simulation was repeated
50 times. In each repetition, 20 true peptides (with
abundance level a and masses randomly selected from
a quality-control Shewanella Oneidensis data set pro-
v i d e db yP N N L[ 3 3 ] )s e r v e da st h ei n p u to ft h ed a t a
model given by Eq. 3. The charge state distribution of
one peptide was modeled by a binomial distribution,
which was reported to approximate the real data well
[27]. The isotopic distribution was obtained for each
p e p t i d eb yu s i n gt h eA v e r a g i n em o d e l[ 2 2 ]a n dt h e
Mercury algorithm [21]. The output consists of a
simulated mass spectrum. BPDA was applied to obtain
the peptide existence probabilities and abundance
results. Its performance was evaluated by the classic
Receiver Operating Characteristic (ROC) curve. To
obtain the ROC curve, first a series of detection levels
τ ranging from 0 to 1 with 0.001 increments was
selected. Peptides with existence probabilities not less
than τ were said to be detected at this specific detec-
tion level. The True Positive Rate (TPR) and False
Positive Rate (TPR) were then calculated at each detec-
tion level as follows:
TPR
TruePositive
TruePositive FalseNegative
=
+
and
FPR
FalsePositive
FalsePositive TrueNegative
=
+
.O n eR O Cc u r v e
(each point on the curve was a pair of TPR and FPR at
one detection level) was plotted for each repetition. And
t h ea v e r a g e dR O Cc u r v ef o ro n ea b u n d a n c el e v e lw a s
obtained by averaging all the ROC curves corresponding
to the same abundance level. We also applied OpenMS
on the same data sets – to do so, we first wrote the
simulated MS data into a text file with three columns
specified by elution time, m/z, and intensity, respec-
tively. Next, the text file was converted to mzXML
(which is a valid input file format for OpenMS) by the
FileConverter tool integrated in the OpenMS software
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mzXML file to give the detection results including
detected features and their qualities. The ROC results
given by the two algorithms for different abundance
levels are shown in Figure 1.
Synthetic 10-mix spectrum with overlapping peptides
As noted before, overlapping peptide peaks can compli-
cate the mass spectra and make the detection problem
much harder. Thus, we investigated the performance of
BPDA in the presence of overlapping peptides. A simu-
lated 10-mix spectrum was generated by 5 pairs of over-
lapping peptides with unique masses: 1264.279,
1266.383, 1382.247, 1388.367, 1293.323, 1294.345,
1312.441, 1313.451, 1327.386 and 1329.378 Da. The
detection results for the comparison between BPDA and
OpenMS are summarized in Table 1. BPDA detected all
10 peptides when FPR = 0.1, with very small mass devia-
tions and quite accurate abundance results. Almost all
charge states of the 10 true peptides were correctly
reported, except for the highest charge state of the 5th
and the 9th peptides. These two charge states were
missed because the corresponding peptide signal was
very weak. In contrast, when FPR =0 . 1 ,O p e n M So n l y
detected the 3rd, the 7th and the 9th peptides. And
when FPR increased to 0.3, OpenMS achieved its high-
e s tT P R( 0 . 6 ) .B u ti tc o u l dd e t e c to n l yo n ep a i ro f
peptides (the one with the least overlap) and missed one
peptide in each of the other 4 pairs. Two examples are
given in Figure 2 to illustrate the observed overlapping
peptide signals and the detection results. The abundance
results given by OpenMS were not close to those of the
true peptides (although the total abundance of each
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Figure 1 ROC results for synthetic 20-mix spectra with different abundance levels (SNRs). ROC results for synthetic 20-mix spectra with
different abundance levels a = 500, 2500 and 12500.
Table 1 Results for synthetic 10-mix spectrum with
overlapping peptides
BPDA OpenMS
True Mass (Da)/Intn/CS dM (Da)/Intn/CS dM (Da)/Intn/CS
1264.279/0.034/1-3 -0.0065/0.032/1-3 NA
1266.383/0.103/1-3 -0.0025/0.110/1-3 -0.0025/0.156/1-3
1382.247/0.171/1-4 0.0028/0.181/1-4 0.0031*/0.228/1-3
1388.367/0.114/1-4 -0.0073/0.097/1-4 -0.0046/0.150/1-3
1293.323/0.006/1-3 -0.0081/0.007/1-2 NA
1294.345/0.008/1-3 -0.0124/0.008/1-3 0.0033/0.018/1-2
1312.441/0.229/1-4 0.0018/0.247/1-4 0.0019*/0.334/1-4
1313.451/0.183/1-4 -0.0061/0.173/1-4 NA
1327.386/0.080/1-4 -0.0035/0.067/1-3 0.0061*/0.114/1-3
1329.378/0.072/1-4 -0.0035/0.078/1-4 NA
Results for the 10-mix data set. Intn, CS and dM denote the normalized
intensity, detectable charge states and the mass deviation from the true mass,
respectively. When FPR = 0.1, BPDA was able to detect all 10 true peptides,
while OpenMS detected only 3 peptides (marked by *). OpenMS achieved its
highest TPR (0.6) when FPR = 0.3.
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ing total abundance of the true peptides). In total, 18
out of 36 charge states were correctly detected by
OpenMS for the 10 peptides, while BPDA correctly
detected 34 out of 36, a much larger number.
We remark that Decon2LS results are missing from
both synthetic experiments described previously because
the synthetic data could not be loaded, causing the pro-
gram to crash (the data was contained in a mzXML file
converted from a 3-column text file by the OpenMS
FileConverter tool, whose format was successfully veri-
fied against mzXML version 2.1). We contacted
Decon2LS’s developers, but did not hear from them in
time to have the Decon2LS results included.
Real data
In this section we report results from experiments car-
ried out with real MS data. The test data and parameter
files used for different software tools were provided as
supplementary files on the BPDA project website. We
stick mainly to the recommended parameter values
while only adjusted a few parameters such as mass
range and detection level to adapt to each data set.
MALDI-TOF MS 7-mix spectrum
We tested BPDA on MALDI-TOF MS 7-mix spectrum,
which contained seven standard peptides with monoisoto-
pic masses 1045.535, 1295.678, 1346.728, 1618.815,
2092.079, 2464.191 and 3146.464 Dalton [35]. The spec-
trum was collected on a Bruker ultraFlex MALDI TOF in
the reflectron mode. As stated before, MALDI mostly gen-
erates singly charged ions, so we only considered charge
state 1 in the test. Since there were contaminants in the
data set, the goal was to check whether a detection
algorithm could find all the seven true peptides. The
detection results of BPDA, Decon2LS, OpenMS, and the
commercial software flexAnalysis developed by Bruker
Daltonics [36] are summarized in Table 2. BPDA detected
the first six peptides with a mean (absolute) mass devia-
tion 0.018 Da. Decon2LS missed the fifth and the last pep-
tides, and the five detected peptides were of a mean mass
deviation 0.013 Da. OpenMS missed the forth and the last
peptides, and the five detected peptides were of a mean
mass deviation 0.025 Da. The commercial software flexA-
nalysis missed the fifth and the last peptides, and the five
detected peptides were of a mean mass deviation 0.013
Da. It can be seen that for the detected peptides, the four
algorithms yielded similar intensity results. Only BPDA
and OpenMS were able to detect the fifth peptide which
had the lowest abundance among the first six peptides.
And all methods failed to report the last peptide. Visual
inspection suggested that this peptide generated very weak
    
(a) (b)
Figure 2 Illustration of overlapping peptides observed in the synthetic 10-mix spectrum. (a) Overlapping peptide signals observed in m/z
range 422-424.5, which is generated by monoisotopic masses 1264.279 and 1266.383 at charge state 3. OpenMS missed the first one while
BPDA detected both. (b) Overlapping peptide signals observed in m/z range 647-650.5, which is generated by monoisotopic masses 1293.323
and 1294.345 at charge state 2. OpenMS missed the first one while BPDA detected both.
Table 2 Results for the MALDI-TOF MS 7-mix spectrum
BPDA OpenMS Decon2LS Bruker
True Masses
(Da)
dM (Da)/
Intn
dM (Da)/
Intn
dM (Da)/
Intn
dM (Da)/
Intn
1045.535 -0.023/0.550 0.019/0.655 -0.021/0.615 -0.023/0.532
1295.678 0.003/0.173 0.026/0.232 0.002/0.168 -0.001/0.167
1346.728 0.017/0.053 0.040/0.070 0.013/0.050 0.011/0.052
1618.815 0.035/0.178 NA 0.024/0.137 0.022/0.202
2092.079 0.021/0.004 0.021/0.009 NA NA
2464.191 -0.012/0.042 0.020/0.034 -0.007/0.030 -0.009/0.047
3146.464 NA NA NA NA
Results for the 7-mix data set. Intn and dM denote the normalized intensity,
and the mass deviation from the true mass, respectively.
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Page 7 of 11signal and its abundance was about one third of the fifth
peptide.
High-resolution LC-MS data set MyoLCMS
The preparation of the MyoLCMS data set is detailed as
below: the data set was collected from an overnight tryp-
tic digest of horse myoglobin. Capillary liquid chromato-
graphy-mass spectrometry (cLC/MS) was performed with
a splitless nanoLC-2 D pump (Eksigent), a 50 mm-i.d.
column packed with 10 cm of 5 mm-o.d. C18 particles,
nanoelectrospray and a high-resolution time-of-flight
mass spectrometer (MicrOTOF; Bruker Daltonics). The
cLC gradient was 2 to 98% 0.1% formic acid/acetonitrile
in 172 seconds at 400 nL/min. Sample was injected at a
concentration of 60 fmol/mL with an injection volume of
10 mL (600 fmol injected on-column).
There were 172 spectra with a m/z range 44.9 to 3005.
To apply BPDA, we first grouped peptide elution peaks,
as described in the Method section. A total of 17 groups
were obtained, each containing 10-20 consecutive spec-
tra. A mean spectrum was generated for each group,
and BPDA was then applied. The detection results of
BPDA, OpenMS, and Decon2LS, which was applied in
conjunction with VIPER [37], are summarized in Addi-
tional file 3: Table S2 (we also considered the method
implemented in the SpecArray package [15], but found
it to be inferior to BPDA, OpenMS, and Decon2LS –
the results were then omitted for the sake of concise-
ness). The number of features with unique monoisotopic
masses detected by BPDA, OpenMS, and Decon2LS-
Viper were 1635, 2176 and 823, respectively. In fact, it
is not very informative to evaluate the performance of a
detection algorithm solely based on the number of
detected features, because of the presence of contami-
nants and false positive detections. Therefore, we focus
on the top detected features yielded by each detection
algorithm. Detected features were ranked by quality in
descending order. Different algorithms utilize different
quality metrics; for example, Decon2LS and OpenMS
p r o v i d eaq u a l i t ys c o r ew h i ch measures how well an
observed isotope pattern matches the predicted isotope
pattern, while BPDA provides the peptide existence
probability (see Eq. 6) as the quality measure. For each
detection algorithm, for a given percentage of top
detected features, we calculated the number of detected
horse myoglobin peptides and the protein coverage rate.
Note that by in-silico digestion of horse myoglobin,
there are 39 tryptic peptides with less than 2 missed
cleavage sites (19 of which do not contain any missed
cleavage sites). Ideally, we should compare algorithms
with known peptide composition in the sample and
report protein coverage at different false positive rates.
However, due to possible peptide contamination in the
sample in any LC/MS experiment, actual peptide species
presented in the sample are never known and this
prevents us from estimating the false positive rates on
the reported peptide list. As a result, the statistical sig-
nificance of reported peptides by different peptide iden-
tification algorithms cannot be evaluated and the only
option left for users in hope of obtaining a list of pep-
tides with relatively low false positive rate is by applying
a percentage threshold on the quality score reported by
different algorithms. Thus, protein coverage v.s. percen-
tage threshold on quality score is a meaningful measure-
ment of the performance of peak detection algorithms
and the results are shown in Figure 3. We need to point
out that although the protein coverage of OpenMS seems
to be comparable with the proposed algorithm in regions
where the quality score percentage threshold is large, in
such regions the reported peptide list may contain a lot
of false positives and it is not an indication of good or
bad algorithm performance. Instead, how quickly an
algorithm reaches high protein coverage as the percen-
tage threshold increases should be the measurement of
the performance. In Figure 3, we can see that BPDA
reaches high protein coverage much faster than other
algorithms at low percentage threshold regions.
Discussion
We observed in our experiments that BPDA performs
well on both simulated data and real data, for various
SNRs and resolutions, and in complex cases where fea-
tures overlap.
For the synthetic 20-mix experiment, we observe in
Figure 1 that the sensitivity (i.e., TPR) of BPDA was con-
sistently higher than that of OpenMS for each abundance
level, and both methods gave better sensitivity results as
the abundance level (i.e., SNR) increased. Also it is
observed that BPDA was quite robust for different SNRs.
For the synthetic 10-mix experiment with overlapping
peptides, we saw that BPDA detected all the peptides at a
small false-positive rate FPR =0 . 1 ,w i t hv e r ys m a l lm a s s
deviations and quite accurate abundance results, and
nearly all the charge states of the 10 true peptides were
correctly reported. In contrast, at FPR =0 . 1 ,O p e n M S
could detect only a few of the peptides. The abundance
results given by OpenMS were not very close to those of
the true peptides. Also OpenMS could only detect about
half of the charge states.
The results obtained with real data corroborated the
findings made with the synthetic experiments. For the
M A L D I - T O FM S7 - m i xd a t a ,t h ef o u ra l g o r i t h m s
yielded similar intensity results, but BPDA was the only
one to detect six out of the seven peptides. For the
MyoLCMS experiment, we focused on protein coverage
results, which is an important criterion to determine the
confidence in protein identification and quantification
[38,39]. It was observed that BPDA displayed the largest
protein coverage among the programs tested.
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We have presented BPDA, a Bayesian approach for
peptide detection. Feature extraction in MS analysis is
difficult because peptides can register multiple peaks.
We model peptide signals based on both charge state
distributions and isotopic distributions. And unlike
perviously published methods, where the detection
only utilizes isotopic distributions and works at each
single charge state alone, BPDA takes into account the
charge state distribution as well, and performs deiso-
toping and charge state deconvolution at the same
time, thus lending information to better identify weak
peptide signals and produce more robust results.
Moreover, the proposed approach is systematic. It is
based on a rigorous statistical framework and avoids
problems, such as voting, thresholding and matching
ambiguities, generally encountered in algorithms based
on template matching.
We have shown that BPDA performs well on both
simulated data and real data, for various SNRs and
resolutions, and in complex cases where features over-
lap. Our experimental results indicate that BPDA com-
pares very favorably with commercial software
flexAnalysis and commonly used open-source soft-
wares such as OpenMS and Decon2LS in terms of
detection performance. As for computational time,
BPDA is a global-based approach, which looks for the
optimal solution iteratively through Gibbs sampling,
while template-matching based algorithms such as
OpenMS and Decon2LS work on a local region at a
time and calculate the fitting score, which typically
does not require much computation. Hence, BPDA is
expected to be more time-consuming than those algo-
rithms, especially when running under the raw data
mode. For example, for 10-mix data set, the running
times for OpenMS and BPDA were 1 minutes and 30
minutes, respectively – although these figures are not
entirely comparable at present, since OpenMS and
Decon2LS are developed using the C programming
language, while BPDA is developed using Matlab; we
plan to translate the Matlab code into C in future
work. In addition, we point out that the user can
choose the centroid mode to run BPDA as a tradeoff
between running time and performance.
Availability and requirements
Project name: BPDA
Project home page: http://gsp.tamu.edu/Publications/
supplementary/sun10a/bpda
Operating system(s): Platform independent
Programming language: Matlab
Licence: GNU GPL (note that we do not allow mate-
rial transfer agreements or software transfer agreements
for academics)
Any restrictions to use by non-academics: licence
needed.
Additional material
Additional file 1: Suppl file 1: Detailed derivations of the likelihood,
the prior distributions and the conditional posterior distributions of
model parameters.
Additional file 2: Table S1: The pseudocode of the Gibbs sampling
process.
0 10 20 30 40 50 60 70 80 90 100
0
10
20
30
40
50
60
70
80
90
100
Protein coverage results
Percentage of top detected features (%)
P
r
o
t
e
i
n
 
c
o
v
e
r
a
g
e
 
r
a
t
e
(
%
)
BPDA
OpenMS
Decon2LS
Figure 3 Results for the LC-MS data set MyoLCMS. Protein coverage results achieved by BPDA, OpenMS, and Decon2LS.
Sun et al. BMC Bioinformatics 2010, 11:490
http://www.biomedcentral.com/1471-2105/11/490
Page 9 of 11Additional file 3: Table S2: Detection results for high-resolution LC-
MS data set MyoLCMS.
Acknowledgements
The authors thank the support of the Partnership for Personalized Medicine
(PPM) project, through Translational Genomics (TGen) contract C08-00904.
The authors thank the RCMI Proteomics Core at UTSA (NIH G12 RR013646) for
assistance with experiment design, sample preparation and data collection for
the horse myoglobin data. The authors thank the Cancer Biology and
Infectious Diseases Research Center at the Eastern Virginia Medical School for
the peptide standard data collected on the Bruker Ultra flex MALDI-TOF.
Jianqiu Zhang’s research is supported by a San Antonio Life Science Institute
research enhancement grant and a grant with award number G12RR013646
from the National Center For Research Resources, USA.
Author details
1Department of Electrical and Computer Engineering, Texas A&M University,
College Station, TX 77843, USA.
2Department of Electrical and Computer
Engineering, University of Texas at San Antonio, San Antonio, TX 78249, USA.
3Computational Biology Division, Translational Genomics Research Institution,
Phoenix, AZ 85004, USA.
4Department of Bioinformatics and Computational
Biology, University of Texas M.D. Anderson Cancer Center, Houston, TX
77030, USA.
Authors’ contributions
YS developed and implemented the algorithm, conducted all simulations
and wrote the initial draft of the paper. JZ conceived the algorithm, advised
YS on algorithm development and revised the paper. UBN advised YS on
the numerical experiments and revised the paper. ERD revised the paper.All
authors read and approved the final manuscript.
Received: 1 June 2010 Accepted: 29 September 2010
Published: 29 September 2010
References
1. Hop C, Bakhtiar R: An introduction to electrospray ionization and matrix-
assisted laser desorption/ionization mass spectrometry: essential tools in
a modern biotechnology environment. Biospectroscopy 1997, 3:259-280.
2. Karas M, Bahr U: Laser desorption ionization mass spectrometry of large
biomolecules. Trends Anal Chem 1990, 9:321-325.
3. Batoy S, Akhmetova E, Miladinovic S, Smeal J, Wilkins CL: Developments in
MALDI mass spectrometry: the quest for the perfect matrix. Appl
Spectrosc Rev 2008, 43:485-550.
4. Hu Q, Noll RJ, Li H, Makarov A, Hardman M, Graham Cooks R: The Orbitrap:
a new mass spectrometer. Journal of mass spectrometry 2005, 40:430-443.
5. Todd JFJ, March RE: Quadrupole ion trap mass spectrometry New York, NY,
USA: Wiley-Interscience 2005.
6. Wollnik H: Time-of-flight mass analyzers. Mass Spectrometry Reviews 1993,
12:89-11.
7. Chernushevich IV, Loboda AV, Thomson BA: An introduction to
quadrupole-time-of-flight mass spectrometry. J Mass Spectrom 2001,
36:849-865.
8. Gross ML, Rempel DL: Fourier transform mass spectrometry. Science 1984,
226:261-268.
9. Zhang J, Gonzalez E, Hestilow T, Haskins W, Huang Y: Review of peak
detection algorithms in liquid-chromatography-mass spectrometry. Curr
Genomics 2009, 10:388-401.
10. Du P, Angeletti RH: Automatic Deconvolution of Isotope-Resolved Mass
Spectra Using Variable Selection and Quantized Peptide Mass
Distribution. Anal Chem 2006, 78:3385-3392.
11. Morris JS, Coombes KR, Koomen J, Baggerly KA, Kobayashi R: Feature
extraction and quantification for mass spectrometry in biomedical
applications using the mean spectrum. Bioinformatics 2005, 21:1764-1775.
12. Coombes KR, Tsavachidis S, Morris JS, Baggerly KA, Hung MC, Kuerer HM:
Improved peak detection and quantification of mass spectrometry data
acquired from surface-enhanced laser desorption and ionization by
denoising spectra with the undecimated discrete wavelet transform.
Proteomics 2005, 5:4107-4117.
13. Du P, Kibbe WA, Lin SM: Improved peak detection in mass spectrum by
incorporating continuous wavelet transform-based pattern matching.
Bioinformatics 2006, 22:2059-2065.
14. Wang Y, Zhou X, Wang H, Li K, Yao L, Wong STC: Reversible jump MCMC
approach for peak identification for stroke SELDI mass spectrometry
using mixture model. Bioinformatics 2008, 24:i407-i413.
15. Li X, Yi EC, Kemp CJ, Zhang H, Aebersold R: A software suite for the
generation and comparison of peptide arrays from sets of data
collected by liquid chromatography-mass spectrometry. S Mol Cell
Proteom 2005, 4:1328-1340.
16. Bellew M, Coram M, Fitzgibbon M, Igra M, Randolph T, Wang P, May D,
Eng J, Fang R, Lin C, Chen J, Goodlett D, Whiteaker J, Paulovich A,
McIntosh M: A suite of algorithms for the comprehensive analysis of
complex protein mixtures using high-resolution LC-MS. Bioinformatics
2006, 22(15):1902-909.
17. Noy K, Fasulo D: Improved model-based, platform-independent feature
extraction for mass spectrometry. Bioinformatics 2007, 23:2528-2535.
18. Jaitly N, Mayampurath A, Littlefield K, Adkins JN, Anderson GA, Smith RD:
Decon2LS: An open-source software package for automated processing
and visualization of high resolution mass spectrometry data. BMC
bioinformatics 2009, 10:87.
19. Sturm M, Bertsch A, Gröpl C, Hildebrandt A, Hussong R, Lange E, Pfeifer N,
Schulz-Trieglaff O, Zerck A, Reinert K, Kohlbacher O: OpenMS - An open-
source software framework for mass spectrometry. BMC Bioinformatics
2008, 9:163.
20. Yergey JA: A general approach to calculating isotopic distributions for
mass spectrometry. Int J Mass Spectrom Ion Phys 1983, 52:337-349.
21. Rockwood AL, Van Orden SL, Smith R: Rapid cacluation of isotope
distributions. Anal Chem 1995, 67:2699-2704.
22. Horn DM, Zubarev RA, McLafferty FW: Automated reduction and
interpretation of high resolution electrospray mass spectra of large
molecules. Journal of the American Society for Mass Spectrometry 2000,
11(4):320-332.
23. Zhang J, Wang H, Suffredini A, Gonzales D, Gonzales E, Huang Y, Zhou X:
Bayesian peak detection for pro-TOF MS MALDI data. Proc of IEEE
International Conference on Acoustics, Speech and Signal Processing (ICASSP)
Las Vegas, NV, USA 2008, 661-664.
24. Du P, Sudha R, Prystowsky MB, Angeletti RH: Data reduction of isotope-
resolved LC-MS spectra. Bioinformatics 2007, 23:1394-1400.
25. Keller A, Nesvizhskii AI, Kolker E, Aebersold R: Empirical statistical model to
estimate the accuracy of peptide identifications made by MS/MS and
database search. Anal Chem 2002, 74:5383-5392.
26. Matlab mspeaks. [http://www.mathworks.com/access/helpdesk/help/
toolbox/bioinfo/ref/mspeaks.html].
27. Schulz-Trieglaff O, Pfeifer N, Gröpl C, Kohlbacher O, Reinert K: LC-MSsim - a
simulation software for liquid chromatography mass spectrometry data.
BMC Bioinformatics 2008, 9:423.
28. Du P, Stolovitzky G, Horvatovich P, Bischoff R, Lim J, Suits F: A noise model
for mass spectrometry based proteomics. Bioinformatics 2008,
24:1070-1077.
29. Coombes KR: Understanding the characteristics of mass spectrometry
data through the use of simulation. Cancer Informatics 2005, 1:41-52.
30. Geman S, Geman D: Stochastic relaxation, Gibbs distributions, and the
Bayesian restoration of images. IEEE Trans Pattern Anal Mach Intell 1984,
6:721-741.
31. Robert CP, Casella G: Monte Carlo Statistical Methods New York, NY, USA:
Springer 2004.
32. Duda R, Hart P: Pattern Classification New York, NY, USA: JohnWiley&Sons
2001.
33. Shewanella Oneidensis data set. [http://omics.pnl.gov].
34. OpenMS/TOPP website. [http://open-ms.sourceforge.net].
35. Bruker peptide calibration standard. [http://www2.bdal.de/data/care-
online_data/206195/PI_206195_Peptide%20Cal%20Stand_V2.pdf].
36. Bruker Daltonics website. [http://www.bdal.de].
Sun et al. BMC Bioinformatics 2010, 11:490
http://www.biomedcentral.com/1471-2105/11/490
Page 10 of 1137. Monroe ME, Tolic N, Jaitly N, Shaw JL, Adkins JN, Smith RD: VIPER: an
advanced software package to support high-throughput LC-MS peptide
identification. Bioinformatics 2007, 23(15):2021-2023.
38. Stead DA, Preece A, Brown JP: Universal metrics for quality assessment of
protein identifications by mass spectrometry. Mol Cell Prot 2006,
5:1205-1211.
39. McHugh L, Arthur JW: Computational Methods for Protein Identification
from Mass Spectrometry Data. PLoS Comput Biol 2008, 4:e12.
doi:10.1186/1471-2105-11-490
Cite this article as: Sun et al.: BPDA - A Bayesian peptide detection
algorithm for mass spectrometry. BMC Bioinformatics 2010 11:490.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Sun et al. BMC Bioinformatics 2010, 11:490
http://www.biomedcentral.com/1471-2105/11/490
Page 11 of 11